Augme
closedStrategic services and mobile technology for consumer and healthcare brands.
Launch date
Employees
Market cap
€104m
Enterprise valuation
€102m (Public information from Sep 2024)
Share price
$2.33 AUGX
New York City New York (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 16.5m | 22.2m | 30.9m | 44.9m | 53.1m | 67.2m | 119m |
| % growth | 17 % | 34 % | 40 % | 45 % | 18 % | 27 % | 78 % |
| EBITDA | (13.7m) | (17.9m) | (22.4m) | (15.6m) | (21.9m) | (17.6m) | 4.6m |
| % EBITDA margin | (83 %) | (81 %) | (72 %) | (35 %) | (41 %) | (26 %) | 4 % |
| Profit | (15.6m) | (17.9m) | (24.4m) | (19.2m) | (28.1m) | (25.4m) | - |
| % profit margin | (95 %) | (81 %) | (79 %) | (43 %) | (53 %) | (38 %) | - |
| EV / revenue | - | 4.1x | 1.9x | 6.3x | 2.1x | 1.7x | 1.1x |
| EV / EBITDA | - | -5.0x | -2.6x | -18.2x | -5.0x | -6.5x | 30.0x |
| R&D budget | 4.5m | 6.7m | 10.1m | 11.2m | - | - | - |
| R&D % of revenue | 27 % | 30 % | 33 % | 25 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
